{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:07:33Z","timestamp":1754154453165,"version":"3.41.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.hbpd.2025.06.005","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:10:18Z","timestamp":1750360218000},"page":"355-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel treatment strategies for pancreatitis: Current status and future prospects"],"prefix":"10.1016","volume":"24","author":[{"given":"Wen-Bin","family":"Zou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Han","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Shen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2025.06.005_bib0001","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.gastro.2024.02.052","article-title":"Diagnosis and management of acute pancreatitis","volume":"167","author":"Trikudanathan","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0002","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(24)02187-1","article-title":"Chronic pancreatitis","volume":"404","author":"Thierens","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012667","article-title":"Autoimmune pancreatitis: from pathogenesis to treatment","volume":"23","author":"Nista","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0004","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cgh.2023.10.021","article-title":"Buprenorphine versus diclofenac for pain relief in acute pancreatitis: a double-blinded randomized controlled trial","volume":"22","author":"Saini","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0005","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2202884","article-title":"Aggressive or moderate fluid resuscitation in acute pancreatitis","volume":"387","author":"de-Madaria","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106737","article-title":"Ward based goal directed fluid therapy (GDFT) in acute pancreatitis (GAP) trial: a feasibility randomised controlled trial","volume":"104","author":"Froghi","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0007","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.hbpd.2025.04.002","article-title":"Fluid therapy in acute pancreatitis comparing balanced solutions and normal saline: a systematic review, meta-analysis and trial sequential analysis","volume":"24","author":"Gao","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106621","article-title":"Impact of low-molecular-weight heparin in the treatment of moderately severe and severe acute pancreatitis; a randomized, single blind, phase 3 control trial","volume":"101","author":"Patil","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.hbpd.2025.06.004","article-title":"Development and validation of a nomogram to predict massive bleeding requiring intervention in severe acute pancreatitis: a retrospective cohort study","volume":"24","author":"Guo","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0010","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/med.21801","article-title":"Mesenchymal stromal cell therapy for pancreatitis: progress and challenges","volume":"41","author":"Ma","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207691","article-title":"MSCs deliver hypoxia-treated mitochondria reprogramming acinar metabolism to alleviate severe acute pancreatitis injury","volume":"10","author":"Hu","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0012","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2468-1253(22)00212-6","article-title":"PROCAP investigators. A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial","volume":"7","author":"Siriwardena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hbpd.2025.06.002","article-title":"Trajectories of prealbumin levels in the early phase of acute pancreatitis are associated with infected pancreatic necrosis","volume":"24","author":"Liu","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0014","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hbpd.2025.06.001","article-title":"Novel drug targets for the early treatment of acute pancreatitis: Focusing on calcium signaling","volume":"24","author":"Chen","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.hbpd.2024.11.002","article-title":"Comparison of the efficacy and safety of basket catheters and balloon catheters for endoscopic pancreatic duct stone clearance","volume":"24","author":"Xiong","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0016","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2022.07.079","article-title":"AGA clinical practice update on the endoscopic approach to recurrent acute and chronic pancreatitis: expert review","volume":"163","author":"Strand","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0017","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.hbpd.2025.05.003","article-title":"Treatment of large pancreatic radiolucent stone","volume":"24","author":"Wang","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0018","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2468-1253(21)00434-9","article-title":"Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Qian","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0019","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.gastro.2023.12.008","article-title":"A randomized controlled phase 2 dose-finding trial to evaluate the efficacy and safety of camostat in the treatment of painful chronic pancreatitis: the TACTIC study","volume":"166","author":"Hart","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0020","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143301","article-title":"Chemical pancreatectomy treats chronic pancreatitis while preserving endocrine function in preclinical models","volume":"131","author":"Saleh","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0021","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/gutjnl-2023-330788","article-title":"Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice","volume":"73","author":"Wang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0022","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cgh.2023.12.010","article-title":"Type 1 autoimmune pancreatitis in Europe: clinical profile and response to treatment","volume":"22","author":"Overbeek","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0023","article-title":"Unraveling the microenvironment and the pathogenic axis of HIF-1\u03b1-visfatin-fibrosis in autoimmune pancreatitis using a single-cell atlas","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0024","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10147-024-02576-2","article-title":"Pancreatic cancer and sarcopenia: a narrative review of the current status","volume":"29","author":"Tsukagoshi","year":"2024","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0025","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17474124.2022.2091544","article-title":"Systematic review of sarcopenia in chronic pancreatitis: prevalence, impact on surgical outcomes, and survival","volume":"16","author":"Bundred","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.06.005_bib0026","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.hbpd.2025.05.002","article-title":"Prevalence and risk factors of skeletal muscle loss and sarcopenia in patients with autoimmune pancreatitis","volume":"24","author":"Sano","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:13:37Z","timestamp":1753355617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387225001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1499387225001018"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.06.005","relation":{},"ISSN":["1499-3872"],"issn-type":[{"type":"print","value":"1499-3872"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel treatment strategies for pancreatitis: Current status and future prospects","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}